查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587793

全EXOME定序市場規模、佔有率、趨勢分析報告：按產品、按技術、按工作流程、按應用、按最終用途、按地區、細分市場預測，2025-2030 年

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

全EXOME定序市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球全EXOME定序市場規模將達到12.725億美元，2024年至2030年複合年成長率為18.44%。

推動市場的主要因素之一是全EXOME定序技術的進步。高通量技術正在廣泛應用於臨床診斷和研究，幫助醫生更好地了解EXOME定序疾病並進行相應的治療。此外，遺傳疾病的日益流行使得能夠採用全EXOME定序來詢問蛋白質轉錄區並獲得有關遺傳變異的有價值的結果。

此外，資料分析和解釋軟體的可用性導致涉及全EXOME的研究顯著增加。使用這些工具和軟體來查詢遺傳資料很容易，並且可以為遺傳異常和疾病的根本原因提供新的見解。例如，2022年5月，Illumina子公司Grail宣布與美國退伍軍人事務部合作，為美國退伍軍人提供Galleri多種癌症早期檢測測試。此測試使用全EXOME定序來早期檢測多種類型的癌症。這種夥伴關係體現了全EXOME定序和先進資料分析工具的使用如何實現大規模基因組研究並改變精準醫學的未來。

市場受到 COVID-19 大流行的嚴重影響。英國基因組學聯盟 (COVID-19 Genomics UK Consortium) 的研究就是利用全EXOME來增進我們對病毒及其傳播的了解的一個例子。這場大流行也引起了人們EXOME定序在對抗感染疾病的前景的關注，並刺激了對該研究領域的額外投資。儘管2020年大流行帶來了挑戰，但預計未來幾年整體市場將持續發展。

全EXOME定序市場報告亮點

  • 消耗品細分市場佔據主導地位，2024年市場佔有率為62.36%。這是因為全EXOMEEXOME定序需要多種耗材，包括試劑、套件和樣品製備耗材，這些對於進行全外顯子定序研究至關重要。
  • 2024年，合成定序領域市場佔有率主導地位。這是因為合成定定序方法的有效性和經濟性增加了它們的吸引力。
  • 由於基因檢測服務和個人化醫療的需求不斷增加，因此定序市場佔有率市佔率將達到49.90%。全EXOME定序能夠以低成本分析大量遺傳資料，並且還可以對遺傳變異進行更全面的分析。
  • 由於在推動新藥開發方面發揮重要作用，藥物發現與開發領域在2024年以47.38%的市場佔有率佔據市場主導地位。全EXOME定序已成為識別基因突變和致病突變的強大方法，可用於開發量身定做的治療方法。
  • 學術和研究機構部分在整個EXOME定序市場中佔據主導地位，到 2024 年將佔據 47.32% 的佔有率。該細分市場的主導地位是由於對個人化藥物和醫療保健的需求不斷成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章產品業務分析

  • 細分儀表板
  • 全EXOME定序市場：產品變異分析
  • 2018-2030 年全EXOME定序市場規模與趨勢分析（依產品）
  • 裝置
  • 消耗品
  • 服務

第5章技術業務分析

  • 細分儀表板
  • 全EXOME定序市場：技術變化分析
  • 2018-2030 年全EXOME定序市場規模與趨勢分析（依技術）
  • SBS（定序定序）
  • ION半導體定序
  • 其他

第 6 章 依工作流程進行業務分析

  • 細分儀表板
  • 全EXOME定序市場：工作流程變化分析
  • 2018-2030 年全EXOME定序市場規模與趨勢分析（依工作流程）
  • 預測定序
  • 定序
  • 其他

第7章 應用業務分析

  • 細分儀表板
  • 全EXOME定序市場：應用變異分析
  • 2018-2030 年全EXOME定序市場規模與趨勢分析（按應用）
  • 臨床診斷
  • 藥物發現與開發
  • 個人化醫療
  • 其他

第 8 章 依最終用途分類的業務分析

  • 細分儀表板
  • 全EXOME定序市場：最終用途變異分析
  • 2018-2030 年全EXOME定序市場規模與趨勢分析（依最終用途）
  • 學術研究所
  • 醫院/診所
  • 製藥和生物技術公司
  • 其他

第9章區域業務分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 北美洲
    • 北美全EXOME定序市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲全EXOME定序市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區全EXOME定序市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲全EXOME定序市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲泛EXOME定序市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 公司分類
  • 策略規劃
  • 2024 年企業市場佔有率分析
  • 公司簡介/
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc
    • BGI
    • PacBio
    • Oxford Nanopore Technologies plc.
    • Azenta US Inc.（GENEWIZ）
    • CD Genomics
    • Novogene Co, Ltd
    • Eurofins Genomics
Product Code: GVR-4-68040-070-5

Whole Exome Sequencing Market Growth & Trends:

The global whole exome sequencing market size is expected to reach USD 1,272.5 million by 2030, registering to grow at a CAGR of 18.44% from 2024 to 2030 according to a new report by Grand View Research, Inc. One of the primary factors driving the market is the advancement in technology for whole exome sequencing. High throughput technology is becoming more widely used in clinical diagnostics and research which helps doctors to better understand the exome sequence disorders and made a treatment accordingly. Additionally, the rising prevalence of genetic conditions has enabled the adoption of whole exome sequencing for the investigation of protein coding regions and the derivation of valuable output about genetic variants.

Additionally, the significant increase in research including whole exomes is driven by the availability of data analysis and interpretation software. The use of these tools and software to examine genetic data is easy and it provides a fresh insight into the underlying causes of genetic abnormalities and diseases. For instance, in May 2022, Illumina's subsidiary Grail, announced a partnership with the U.S. Department of Veterans Affairs, to provide their Galleri multi-cancer early detection test to U.S. veterans. This test utilizes whole exome sequences to detect multiple types of cancer in the early stages. This partnership exemplifies how the usage of whole exome sequencing and advanced data analysis tools can enable large-scale genomic research and transform the future of precision medicine.

The market has been significantly impacted by the COVID-19 pandemic. An example of how whole exomes have been used to better understand the virus and its dissemination is the COVID-19 Genomics UK Consortium study. The pandemic has also brought attention to the promise of exome sequence in the fight against infectious diseases, spurring additional investment in this field of study. The entire market is anticipated to develop in the upcoming years despite difficulties brought on by the pandemic in 2020.

Whole Exome Sequencing Market Report Highlights:

  • The consumables segment dominated the market in 2024 with a market share of 62.36%. This is due to whole exome sequencing's requirement of a variety of consumable items, including reagents, kits, and sample preparation consumables, which are essential for conducting whole exome sequencing investigations.
  • Sequencing by synthesis segment dominated the market in 2024 with a market share of 73.49%. This is due to the effectiveness and affordability of the sequencing by synthesis approach that has increased its appeal.
  • The sequencing segment had a dominating presence in the market in 2024 with a market share of 49.90%, due to the growing demand for genetic testing services and personalized medicine. Whole exome sequencing has the ability to analyze large number of genetic data in a less cost, additionally it allows for more comprehensive analysis of genetic variation.
  • Drug discovery & development segment dominated the market in 2024 with a market share of 47.38% due to it plays a crucial part in advancing the development of new drugs. Whole exome sequencing has become a compelling method for locating gene variations and disease-causing mutations that can be exploited to create tailored treatments.
  • The academic & research institutes segment in whole exome sequencing market dominated the market in 2024, with a share of 47.32%. The dominance of the segment is due to the increasing demand for personalized medicines and healthcare.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Workflow Segment
      • 1.1.1.4. Application Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Prevalence of Genetic Diseases
      • 3.2.1.2. Technological Advancements in Sequencing Platforms and Data Analysis Tools
      • 3.2.1.3. Decreasing Costs of Sequencing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Complexity and Costs Associated with Data Storage, Interpretation & Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Whole Exome Sequencing Market: Product Movement Analysis
  • 4.3. Whole Exome Sequencing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Whole Exome Sequencing Market: Technology Movement Analysis
  • 5.3. Whole Exome Sequencing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Sequencing by Synthesis
    • 5.4.1. Sequencing By Synthesis Market, 2018 - 2030 (USD Million)
  • 5.5. ION Semiconductor Sequencing
    • 5.5.1. ION Semiconductor Sequencing Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other Technology Market, 2018 - 2030 (USD Million)

Chapter 6. Workflow Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Whole Exome Sequencing Market: Workflow Movement Analysis
  • 6.3. Whole Exome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 6.4. Pre-Sequencing
    • 6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Sequencing
    • 6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Other Workflow Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Whole Exome Sequencing Market: Application Movement Analysis
  • 7.3. Whole Exome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Clinical Diagnostics
    • 7.4.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Drug Discovery & Development
    • 7.5.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 7.6. Personalized Medicines
    • 7.6.1. Personalized Medicines Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 8. End Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Whole Exome Sequencing Market: End Use Movement Analysis
  • 8.3. Whole Exome Sequencing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Academic And Research Institutes
    • 8.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical & Biotechnology Companies
    • 8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Other End use Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. North America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. U.S. Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Canada Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Mexico Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. UK Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Germany Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. France Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Italy Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Spain Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Denmark Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Sweden Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Norway Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Japan Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. China Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. India Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Australia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Thailand Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. South Korea Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Brazil Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Argentina Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. South Africa Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Saudi Arabia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. UAE Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Kuwait Whole Exome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Illumina, Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Agilent Technologies, Inc
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. BGI
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PacBio
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Oxford Nanopore Technologies plc.
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Azenta US Inc. (GENEWIZ)
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. CD Genomics
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Novogene Co, Ltd
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Eurofins Genomics
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global whole exome sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America Whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America Whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. whole Exome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 17 U.S. whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Canada whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Canada whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Mexico whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Mexico whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Europe whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Europe whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 36 UK whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 38 UK whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 39 UK whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Germany whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Germany whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Germany whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Germany whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Germany whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 46 France whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 47 France whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 France whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 49 France whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Italy whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Italy whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Italy whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Spain whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Spain whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 58 Spain whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Denmark whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 63 Denmark whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Sweden whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Sweden whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 69 Sweden whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Norway whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Norway whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 73 Norway whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Norway whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 82 Japan whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Japan whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Japan whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 China whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 87 China whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 88 China whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 89 China whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 90 China whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 India whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 92 India whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 93 India whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 94 India whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 95 India whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Australia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 97 Australia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 99 Australia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 100 Australia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Thailand whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 102 Thailand whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 104 Thailand whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 105 Thailand whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 South Korea whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 107 South Korea whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 108 South Korea whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 109 South Korea whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 110 South Korea whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Latin America whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 115 Latin America whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Brazil whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 120 Brazil whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 125 Argentina whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 Middle East & Africa whole exome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 136 South Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 145 UAE whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 146 UAE whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait whole exome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 151 Kuwait whole exome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Global whole exome sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Global whole exome sequencing market driver analysis
  • Fig. 12 Global whole exome sequencing market restraint analysis
  • Fig. 13 Global whole exome sequencing market: Porter's analysis
  • Fig. 14 Global whole exome sequencing market: PESTEL analysis
  • Fig. 15 Global whole exome sequencing market: Product movement analysis
  • Fig. 16 Global whole exome sequencing market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global whole exome sequencing market, for consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global whole exome sequencing market, for services, 2018 - 2030 (USD Million)
  • Fig. 19 Global whole exome sequencing market: Technology movement analysis
  • Fig. 20 Global whole exome sequencing market, for sequencing by synthesis, 2018 - 2030 (USD Million)
  • Fig. 21 Global whole exome sequencing market, for ION semiconductor sequencing, 2018 - 2030 (USD Million)
  • Fig. 22 Global whole exome sequencing market, for other technology, 2018 - 2030 (USD Million)
  • Fig. 23 Global whole exome sequencing market: Workflow movement analysis
  • Fig. 24 Global whole exome sequencing market, for pre-sequencing, 2018 - 2030 (USD Million)
  • Fig. 25 Global whole exome sequencing market, for sequencing, 2018 - 2030 (USD Million)
  • Fig. 26 Global whole exome sequencing market, for data analysis, 2018 - 2030 (USD Million)
  • Fig. 27 Global whole exome sequencing market: Application movement analysis
  • Fig. 28 Global whole exome sequencing market, for clinical diagnostics, 2018 - 2030 (USD Million)
  • Fig. 29 Global whole exome sequencing market, for drug discovery & development, 2018 - 2030 (USD Million)
  • Fig. 30 Global whole exome sequencing market, for personalized medicine, 2018 - 2030 (USD Million)
  • Fig. 31 Global whole exome sequencing market, for other applications, 2018 - 2030 (USD Million)
  • Fig. 32 Global whole exome sequencing market: End use movement analysis
  • Fig. 33 Global whole exome sequencing market, for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 34 Global whole exome sequencing market, for hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Global whole exome sequencing market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global whole exome sequencing market, for other end use, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional outlook, 2024 & 2030
  • Fig. 39 Global whole exome sequencing market: Region movement analysis
  • Fig. 40 North America whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 46 UK whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 47 France whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 55 China whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 56 India whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE whole exome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait whole exome sequencing market, 2018 - 2030 (USD Million)